GWAS in NMDAR Encephalitis

计划入组 2,000 人 · 首次发布于 2022 年 2 月 7 日

A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric Disease

计划入组 30 人 · 首次发布于 2025 年 7 月 30 日

A Case Report of NMDAR Encephalopathy

计划入组 1 人 · 首次发布于 2025 年 4 月 8 日

2C-TFM

aLAG3​-IL-2c

GO-203-2C

C₈₉H₁₇₀N₅₂O₂₀S₂

OPENLANE

United States

ReST Therapeutics Receives FDA Clearance for First-in-Human Trial of Novel Early PTSD Intervention RST-101

Dynamic Single-Cell Transcriptomic Analysis Reveals Immune Dysregulation in Anti-NMDAR Encephalitis

SLC6A20-Targeting ASO Restores NMDA Receptor Function in Autism Models, Offering New Therapeutic Strategy